A multi-layer transdermal drug delivery system containing ibuprofen or a structural analogue thereof, comprising a transdermal patch containing ibuprofen or a structural analogue thereof and a second combined layer. The transdermal patch comprises a polymer matrix layer, the polymer matrix layer comprising an active ingredient, a compound containing at least one amino group, and a pressure-sensitive adhesive. All or some of active ingredient-amino compound salts or all or some of free active ingredients formed in the polymer matrix layer are kept in a uniform dissolution state in the polymer matrix, and can be stably stored before use, without recrystalization. The transdermal drug delivery system can continuously and controllably deliver a therapeutically effective amount of ibuprofen or a structural analogue thereof for 12 to 24 hours in the absence of a transdermal enhancer, has excellent wearing ability, and avoids a cold flow phenomenon.
一种含有
布洛芬或其结构类似物的多层透皮给药系统,包括一个含有
布洛芬或其结构类似物的透皮贴片和一个第二组合层。透皮贴片包括聚合物基质层,聚合物基质层包括活性成分、含有至少一个
氨基的化合物和压敏粘合剂。聚合物基质层中形成的全部或部分活性成分-
氨基化合物盐或全部或部分游离活性成分在聚合物基质中保持均匀溶解状态,使用前可稳定保存,不会再结晶。该透皮给药系统在不使用透皮增强剂的情况下,可在 12 至 24 小时内连续、可控地给药治疗有效量的
布洛芬或其结构类似物,具有良好的耐磨性,并可避免冷流现象。